FDA halts imports of several Sun Pharma drugs made in India due to outstanding quality issues

FDA halts imports of several Sun Pharma drugs made in India due to outstanding quality issues

Source: 
Endpoints
snippet: 

A drug manufacturing site that has garnered a lot of attention from the FDA this year has been handed an import alert from the US regulator, blocking certain drugs from entering the country.